• March 19-23, San Francisco

    2012 Joint Summits on Translational Science

    AMIA presents two essential back-to-back meetings for TBI and CRI scientists working throughout the spectrum of translational science. A ‘Bridge Day’ joins the two summit meetings for a day of shared sessions, a keynote, and informational exchange.

2012 Joint Summits Keynote Speakers

Monday, March 19, 2012

Trey Ideker, PhD, Division Chief of Medical Genetics at University of California San Diego School (UCSD) of Medicine, and pioneer in using genome-scale measurements to construct network models of cellular processes and disease. Recognized by the International Society for Computational Biology for outstanding contributions to the field. Featured in Forbes, The Scientist, and The San Diego Union Tribune.

Tuesday, March 20, 2012

Howard J. Jacob, PhD, Director, Human and Molecular Genetics Center and Professor of Physiology and Pediatrics at Medical College and Children’s Hospital of Wisconsin, is best-known for his success using genome sequencing to identify a casual mutation that led to treatment of a 6-year-old boy with an extreme form of inflammatory bowel disease.

Wednesday, March 21, 2012

Robert M. Califf, MD, Vice Chancellor for Clinical Research at Duke University’s Translational Medicine Institute, and Professor of Medicine in the Institute’s Division of Cardiology, has led some of the best-known clinical trials and health outcomes studies in cardiovascular medicine and has published more than 1,000 peer-reviewed original articles in collaboration with his colleagues. He is currently the seventh most frequently cited author in the field of medicine, according to the Institute for Scientific Information — a leader in the fields of quality of care, technology development and health policy.

Russ Altman, MD, PhD, Professor of Bioengineering, Genetics, and Medicine (and Computer Science, by courtesy), Chairman, Department of Bioengineering, Director, Biomedical Informatics Training Program, Stanford University. This presentation focuses on the importance of Translational Bioinformatics continued growth in biomedical research, genetics, education, and diagnostic and therapeutic discovery. In the past year, we have seen continued progress in linking clinical data to molecular data, as we usher in a new era of molecular medicine. This session will review notable publications over the past twelve months, highlighting trends and milestones achieved in the past year. This is the fifth installment of this keynote talk by Dr. Altman.

Friday, March 23, 2012

Peter Embi, MD, MS, Associate Professor and Vice Chair, Department of Biomedical Informatics Chief Research Information Officer, The Ohio State University Medical Center. Dr. Embi is an internationally recognized researcher and educator in the field of clinical research informatics, with numerous publications and presentations describing his innovations in the field. Dr. Embi has received numerous awards for his distinguished work in rheumatology including the 2008 Association of Rheumatology Health Professionals President’s Award. He currently serves on the American College of Rheumatology’s board of directors. In 2008 he was elected as a fellow in the American College of Physicians.